(2019)
Bevacizumab-associated glomerular microangiopathy.
Mod Pathol 32(5),
684-700.
Publikationen
(2019)
Thrombotische Mikroangiopathie: Was gibt es Neues?
Der Nephrologe 14(1),
26-31.
(Review)
(2019)
Author Correction: Immune evasion of Borrelia miyamotoi: CbiA, a novel outer surface protein exhibiting complement binding and inactivating properties.
Sci Rep 9(1),
7056.
(2019)
Complement 5a receptor polymorphisms are associated with PVL-positive Staphylococcus aureus colonization in African Pygmies.
Clin Infec Dis 68(5),
854-856.
(2019)
Biosynthesis of diverse antimicrobial and antiproliferative acyloins in anaerobic bacteria.
ACS Chem Biol 14(7),
1490-1497.
(2019)
C3 glomerulopathy – Understanding a rare complement-driven renal disease.
Nat Rev Nephrol 15(3),
129-143.
(Review)
(2019)
Duckweed for human nutrition: No cytotoxic and no anti-proliferative effects on human cell lines.
Plant Foods Hum Nutr 74(2),
223-224.
(2019)
Recombinant production of MFHR1, a novel synthetic multitarget complement inhibitor, in moss bioreactors.
Front Plant Sc 10,
260.
(2019)
Cyclopropanol warhead in malleicyprol confers virulence of human- and animal-pathogenic Burkholderia species.
Angew Chem Int Ed 58(40),
14129-14133.
(2019)
Elucidating the immune evasion mechanisms of Borrelia mayonii, the causative agent of lyme disease.
Front Immunol 10,
2722.